205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
17.55%
Net income growth under 50% of AVGO's 46.23%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-0.40%
Negative yoy D&A while AVGO is 0.12%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
11.76%
Some yoy growth while AVGO is negative at -143.06%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
9.52%
SBC growth while AVGO is negative at -5.14%. John Neff would see competitor possibly controlling share issuance more tightly.
106.69%
Less working capital growth vs. AVGO's 238.60%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
157.85%
AR growth well above AVGO's 212.24%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-6550.00%
Both reduce yoy inventory, with AVGO at -125.00%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
23.73%
Lower AP growth vs. AVGO's 99.15%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
87.54%
Some yoy usage while AVGO is negative at -120.21%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
125.00%
Well above AVGO's 87.69%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
102.12%
Operating cash flow growth above 1.5x AVGO's 38.37%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
19.25%
Some CapEx rise while AVGO is negative at -37.04%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
61.46%
Purchases growth of 61.46% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
10.50%
Liquidation growth of 10.50% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-2380.00%
We reduce yoy other investing while AVGO is 144.44%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
73.97%
Investing outflow well above AVGO's 100.22%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
33.24%
Debt repayment above 1.5x AVGO's 1.87%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
-40.41%
Negative yoy issuance while AVGO is 145.95%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
46.25%
We have some buyback growth while AVGO is negative at -29.59%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.